当前位置: X-MOL 学术Channels › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma
Channels ( IF 3.3 ) Pub Date : 2021-09-08 , DOI: 10.1080/19336950.2021.1968592
Liang Chen 1 , Zhonghua Yang 1 , Yuan Cao 2 , Yiming Hu 3 , Wei Bao 4 , Dan Wu 5 , Li Hu 6 , Jiaheng Xie 7 , Hongzhu Yu 1
Affiliation  

ABSTRACT

Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. Many patients with hepatocellular carcinoma are diagnosed at an advanced stage because the early symptoms are not obvious. For advanced hepatocellular carcinoma, immunotherapy and targeted therapy seem to be a promising direction. Finding a new prognostic marker for hepatocellular carcinoma and exploring its role in the immune microenvironment is of great value. ABCC transporters have previously been associated with drug resistance in hepatocellular tumors, but the exact mechanism remains unclear. Here, we conducted a study on ABCC5 in HCC and found that the expression of ABCC5 was up-regulated in HCC and was associated with poor prognosis. Further exploration revealed that ABCC5 was associated with immune infiltration of hepatocellular carcinoma. Single-cell analysis revealed a potential relationship between ABCC5 and immune cell differentiation. Therefore, it is significant to continue to explore the role of ABCC5 in hepatocellular carcinoma.



中文翻译:

泛癌分析和单细胞分析揭示了ABCC5转运蛋白在肝细胞癌中的作用

摘要

肝细胞癌(HCC)是最常见的肝癌亚型。由于早期症状不明显,许多肝细胞癌患者被诊断为晚期。对于晚期肝细胞癌,免疫治疗和靶向治疗似乎是一个有希望的方向。寻找新的肝细胞癌预后标志物并探索其在免疫微环境中的作用具有重要价值。ABCC 转运蛋白以前与肝细胞肿瘤的耐药性有关,但确切的机制仍不清楚。在这里,我们对 HCC 中的 ABCC5 进行了研究,发现 ABCC5 在 HCC 中的表达上调,并且与预后不良有关。进一步探索发现ABCC5与肝细胞癌的免疫浸润有关。单细胞分析揭示了 ABCC5 与免疫细胞分化之间的潜在关系。因此,继续探索ABCC5在肝细胞癌中的作用具有重要意义。

更新日期:2021-09-08
down
wechat
bug